News
Feb
20
Notice of Annual General Meeting of Genovis AB (publ)
Feb
13
Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine
Feb
7
Date change for Annual General Meeting and reports
Contact Info


Genovis AB
Box 790, SE-22007, Lund Sweden
Phone: +46(0) 46 101230
Fax: +46(0) 46 128020



Genovis provides products and services relting to antibody engineering enzymes and nanoparticles for imaging applications.

Antibody fragmentation

Products and solutions for fast and accurate fragmentation of antibodies into F(ab')2 and Fab' fragments

Antibody deglycosylation

Soultions for deglycosylation of native IgG

Nanoparticles

Multifunctional nanoparticles for preclinical imaging and services for custom conjugation to nanoparticles